Later On

A blog written for those whose interests more or less match mine.

Trusting Big Business: Eli Lilly edition

leave a comment »

Should we trust large corporations to by and large do the right thing? Does a chicken have lips? Recent item:

Internal documents from the global drug company Eli Lilly reveal that it trained its sales force to avoid discussing the diabetes risk from Zyprexa, a drug used to treat schizophrenia and bipolar disorder. After research revealed that some patients gained weight and had high blood sugar levels that presented an increased risk of diabetes, an internal company sales document stated that “we believe it is essential to weaken this link to neutralize the diabetes/hyperglycemia issue. … Neutralizing any concern from our customers will be essential to the future growth of Zyprexa in the marketplace,” reports Bloomberg. The document came to light during court proceedings in Alaska. In 2002, the drug’s sales force was advised, “We will NOT proactively address the diabetes concern. … The competition wins if we are distracted into talking about diabetes.”

Source: Bloomberg, July 31, 2008

Written by Leisureguy

4 August 2008 at 10:06 am

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: